Skip to main content
Category

News

News
January 15, 2021

Discovering and advancing the world’s first treatments for chronic pancreatitis with Healx

We are elated to announce that Healx, an AI-powered technology company that shares our passion for patient-centered care, has chosen to team up with Mission: Cure to help find a cure for chronic pancreatitis! Mission: Cure was chosen from among many rare disease organizations to be part of Healx's Rare Treatment Accelerator Program (RTA) with the aim of starting a…
Clinical TrialsNews
November 17, 2020

Volunteers Needed for Pancreatitis Research Study

Volunteers Needed Precision Care Network is collecting nasal cells to support research focused on improving medical care for people who have been diagnosed with pancreatitis or are at high risk for developing pancreatitis. Donating nasal cells takes less than five minutes. Eligibility Must be 18 years or older and Have a pancreatitis diagnosis, or Be at high risk of developing…
News
November 6, 2020

Drug Development With a Patient Focus

Picture from: National Pancreas Foundation Pancreatitis Externally-Led Patient-Focused Drug Development Meeting Mission: Cure was one of many patient advocacy nonprofit organizations that participated in the development of the very first Voice of the Patient Report, a months-long project led by the National Pancreas Foundation. In March, during the Patient-Focused Drug Development (PFDD) meeting, Co-Founder and pancreatitis patient Eric Golden shared…
News
September 11, 2020

Survey to Assess the Financial Implications of Pancreatitis

Mission: Cure was established in 2017 to improve patient outcomes, find effective treatments and, ultimately, a cure for pancreatitis. Over the last three years, patients have consistently shared their dismal experience and the financial toll of navigating the medical system in search of a diagnosis and/or a treatment plan while suffering with pain, hopelessness, and poor outcomes. We are conducting…
News
August 20, 2020

Now Hiring: Volunteer Development Intern

About Mission: Cure Mission: Cure was founded in 2017 to find effective treatments and, ultimately, a cure for pancreatitis, an extremely painful, degenerative and costly disease. Led by Megan Golden, a leader in innovative, outcome-based financing such as “Social Impact Bonds,” and Linda Martin, a veteran technology entrepreneur, Mission: Cure is pioneering a new funding model that creates new incentives…
News
August 3, 2020

New Clinical Trial for Chronic Pancreatitis Patients

If you: Have chronic pancreatitis or pancreatic cancer, AND Have been diagnosed with diabetes, Are between the ages of 40 and 85, you may be elegible to participate in a new research study funded by the National Institutes of Health (NIH). The study seeks to develop a blood test that can separate diabetes caused by pancreatic cancer or chronic pancreatitis…
Zoom screenshot of the Mission: Cure team
News
June 17, 2020

Introducing Mission: Cure’s Summer 2020 Intern Cohort!

This summer, Mission: Cure is excited to welcome nine incredible interns to our team. As our largest summer intern cohort ever, they have been busy in these past few weeks learning about chronic pancreatitis and Mission: Cure's model and speaking with other individuals in Mission: Cure's network. Despite not being able to be physically together, this already promises to be…
News
November 2, 2017

New Venture Launched to Harness Innovative Financing and Impact Investing to Cure Disease; “Mission: Cure” Pioneers New Approach by Attacking Pancreatic Disease

FOR IMMEDIATE RELEASE “Mission: Cure” Launched to Harness Innovative Financing and Impact Investing to Cure Disease; Pioneers New Approach by Attacking Pancreatic Disease New York, New York, Tuesday, November 7, 2017—The new nonprofit Mission: Cure will convene the world’s leading pancreatic experts at the American Pancreatic Association meeting in San Diego on November 10th to devise a 10-year plan to…
News
March 1, 2019

Potential Chronic Pancreatitis Treatments Identified

On February 28, 2019, Rare Disease Day, an alliance of leading life-science companies, in partnership with Mission: Cure, announced the promising results of a 4-month "datathon" aimed at identifying potential treatments for chronic pancreatitis. Using artificial intelligence and statistical techniques, datathon participants identified 4 existing, approved drugs as repurposing candidates worth testing as possible cures for pancreatitis. New Pancreatitis Treatment…
News
December 4, 2017

Webinar: Impact bonds for health

Megan Golden presented Mission: Cure's strategy on the Brookings "Impact Bonds for Health" Webinar on December 12th. View the presentation below. For more information please follow this link to the Brookings Website.
Cookie Policy Privacy Policy